Greg Medlock
gregmedlock.bsky.social
Greg Medlock
@gregmedlock.bsky.social
Sr Director R&D @ Vedanta Biosciences. Interested in restoring and controlling the human microbiome.
Looks interesting
ACG International Virtual Grand Rounds — The Paradigm Shift from FMT to Live Biotherapeutic Products in the Treatment of Recurrent Clostridioides difficile Infection

Wednesday, February 4 at 7:00 am ET
➡️ gi.org/ACGVGR
February 3, 2026 at 3:30 AM
My parking spot today
January 28, 2026 at 6:34 PM
Tried Edison Analysis (not Kosmos) on two tasks and was blown away:

1. Uploaded 96 high-res NMR spectra of bacterial supernatants and asked for metabolite ID and quantification

2. Uploaded a bacterial genome and asked it to identify mobile genetic elements (more complex, but this is the gist)
Give it a try here: platform.edisonscientific.com

And read our paper: edisonscientific.com/kosmos-report

We have built this to accelerate science, and we think it's pretty neat. We are super excited to see what people think.
Edison Platform
AI Agents for Scientific Discovery
platform.edisonscientific.com
January 15, 2026 at 4:17 PM
Old news by now, but this is a fantastic short course—feels like Andrew Ng’s early coursera neural networks class. If you have not tried Claude Code, I recommend just skimming the videos to see what the chatter is about.

www.deeplearning.ai/short-course...
Claude Code: A Highly Agentic Coding Assistant
Explore, build, and refine codebases with Claude Code.
www.deeplearning.ai
January 3, 2026 at 9:18 PM
Reposted by Greg Medlock
Antimicrobial resistance (AMR) is one of the greatest threats to public health, with the potential to undo decades of medical progress.

This #WAAW2025, head to our LinkedIn to hear from world-leading experts on how we can tackle AMR and protect the future of medicine: t.ly/3Oxk1
#worldamrawarenessweek #waaw2025 | LifeArc
Antimicrobial resistance (AMR) is one of the greatest threats to public health, with the potential to reverse decades of medical progress. Despite the severity of the problem, the pipeline for new dr...
t.ly
November 21, 2025 at 12:29 PM
Reposted by Greg Medlock
Registration is now open for @keystonesymposia.bsky.social "Beyond #Antibiotics: Emerging Strategies Combating #BacterialInfection." Deadline for scholarships and abstract selected short talks is Jan 7! Join us this May for an amazing meeting! keysym.us/KSBeyondAntibiotics26 #KSBeyondAntibiotics26
Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection | Keystone Symposia
Join us at the Keystone Symposia on Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection, May 2026, in Breckenridge, with field leaders!
keysym.us
November 19, 2025 at 5:37 PM
I'll be speaking at Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection @keystonesymposia.bsky.social May 4-7, 2026. Abstract and scholarship submissions are open through Jan 7. Please encourage those in your network working on novel infection prevention/treatment to submit!
November 4, 2025 at 3:36 PM
Reposted by Greg Medlock
Incredibly powerful story from endocrinologist Dr. Caroline Fox candidly sharing her experience w an acute mental health crisis & her long, difficult, maddening, deeply inspiring journey towards recovery - & return to work as a senior biopharma R&D leader. www.youtube.com/watch?v=YVWS...
Mental Health Journey to Wellness, Gratitude, and Purpose
YouTube video by Caroline Fox
www.youtube.com
October 12, 2025 at 8:15 PM
Largely agree with this—clinical validation of drugs is an extremely small N universe, and it’s not feasible to validate human- vs AI-generated hypothesis prob of success. AI is much better suited to solving the sub-problems in drug dev (which vanilla machine learning was already pretty good at).
@julienmichel, not on #Bluesky, on the use of AI for new drug target discovery and new drug discovery efforts #biotech #AI #superintelligence #biology #valleyofdeath
October 20, 2025 at 1:52 PM
Amazing resource—hope it gets used broadly and we see TnSeq datasets become more common for Bacteroidales.
Excited to share our preprint led by Carlos Voogdt et al

We developed new genetic tools & genome-wide libraries for species of the Bacteroidales order; constructed saturated barcoded transposon libraries in key representatives of three genera.
www.biorxiv.org/content/10.1...
October 13, 2025 at 8:43 PM
Things I love about London: BOLLARDS
October 2, 2025 at 7:55 AM
Reposted by Greg Medlock
🚨 Microbiologists! We are recruiting Assistant / Associate Professors in 3 collaborative areas of our U. Pittsburgh School of Medicine.
1) MMG (my dept): fundamental research in med micro
2) Peds ID / I4Kids institute
3) Center for Vaccine Research
🔗 to all 3 w/info: www.linkedin.com/posts/vaughn...
Faculty Professor Associate - Full-Time | Vaughn Cooper
We are recruiting Faculty microbiologists in three (3) different, complementary, and collaborative areas at the University of Pittsburgh associated with the School of Medicine. 1) Fundamental researc...
www.linkedin.com
September 23, 2025 at 10:31 PM
Reposted by Greg Medlock
Report: You To Be Fired For Reading This Headline About Charlie Kirk
Report: You To Be Fired For Reading This Headline About Charlie Kirk
NEW YORK—Insisting your fate was sealed the moment you clicked the link, a report released Tuesday found that you will be fired for reading this headline about Charlie Kirk. “Shortly after you navigat...
theonion.com
September 16, 2025 at 3:03 PM
Reposted by Greg Medlock
Such a delight to share our work on the evolution of a cheese rind fungus in @currentbiology.bsky.social.

This is the fantastic PhD work of @nicolasleonlouw.bsky.social and resulted from amazing collaborations, a wedding proposal(!), an undergrad course, & more!

🧵

www.cell.com/current-biol...
Long-term monitoring of a North American cheese cave reveals mechanisms and consequences of fungal adaptation
Using a unique longitudinal sampling approach, Louw et al. demonstrate how a cheese-associated Penicillium population has adapted in an artisan cheese production facility in Vermont, USA. Adaptation i...
www.cell.com
September 16, 2025 at 3:56 PM
Reposted by Greg Medlock
Preprint out for myloasm, our new nanopore / HiFi metagenome assembler!

Nanopore's getting accurate, but

1. Can this lead to better metagenome assemblies?
2. How, algorithmically, to leverage them?

with co-author Max Marin @mgmarin.bsky.social, supervised by Heng Li @lh3lh3.bsky.social

1 / N
High-resolution metagenome assembly for modern long reads with myloasm https://www.biorxiv.org/content/10.1101/2025.09.05.674543v1
September 7, 2025 at 11:35 PM
Reposted by Greg Medlock
We published a new lane of research today on human gut fungi. Shout out to 1st author @emilyvansyoc.bsky.social sky.social & @erdavenport.bsky.social For 20 years, bacteria received the lion's share of interest in the human gut. Yet we know little about the gut mycobiome. doi.org/10.1371/jour...
Gut fungi are associated with human genetic variation and disease risk
In contrast to decades of research on gut bacteria, human genetic determinants of the gut fungal community (mycobiome) remain understudied. This investigation presents the first GWAS on the number and...
doi.org
September 2, 2025 at 7:31 PM
Reposted by Greg Medlock
Optimizing storage, high-molecular weight DNA extraction and genome reconstructions from human faecal samples. https://www.biorxiv.org/content/10.1101/2025.08.27.672560v1
August 30, 2025 at 12:17 AM
Cryptosporidium parvum multidrug resistance protein confers resistance to toxic gut microbial metabolite

Wonder how frequent this variability in bile acid sensitivity is across bacterial pathogens!

www.cell.com/cell-host-mi...
Cryptosporidium parvum multidrug resistance protein confers resistance to toxic gut microbial metabolite
Huang et al. identify a multidrug-resistance-associated ABC transporter, CpMRP1, as a genetic determinant of pathogenicity in Cryptosporidium parvum. Through genetic mapping and functional assays, the...
www.cell.com
August 28, 2025 at 7:55 PM
Very neat, looking forward to exploring this hypothesis with gut microbes. Nice work @sulheim.bsky.social
So excited to share this new paper by @sulheim.bsky.social and others! It's rare that you find a pattern, propose a hypothesis and the more you look, the more data you find that fits! Snorre's intuition, hard work and rigour to put it all together have been inspiring! Let us know what you think...
Excited to share the first results from my postdoc at @dmf-unil.bsky.social with @saramitri.bsky.social
www.biorxiv.org/content/10.1...
August 23, 2025 at 3:23 AM
Reposted by Greg Medlock
This work is finally published! 🥳🧬
Plasmids are associated with very variable fitness costs in their different bacterial hosts. But, what is the contribution of each of the plasmid-genes in these host-specific effects? Study led by
@jorgesastred.bsky.social, @sanmillan.bsky.social and myself! 1/14
Dissecting pOXA-48 fitness effects in clinical Enterobacterales using plasmid-wide CRISPRi screens
Nature Communications - This study investigates the effects of the carbapenem resistance plasmid pOXA-48 in clinical enterobacteria. Using CRISPRi screens, the authors revealed that the...
rdcu.be
August 20, 2025 at 1:25 PM
Vedanta has an opening for a contract QC analyst. Please share with your network! The ideal candidate will have both micro and molecular biology experience.

job-boards.greenhouse.io/vedantabiosc...
Contract - Quality Control Specialist
Cambridge, MA
job-boards.greenhouse.io
August 7, 2025 at 5:24 PM
Reposted by Greg Medlock
Breaking: The Gates Foundation said it would commit $2.5 billion through 2030 to support women’s health initiatives, its largest funding commitment ever to the issue.
www.statnews.com/2025/08/04/b...
Gates Foundation pledges $2.5 billion to women’s health initiatives
Breaking: The Gates Foundation said it would commit $2.5 billion through 2030 to support women’s health initiatives, its largest funding commitment ever to the issue.
www.statnews.com
August 4, 2025 at 2:09 PM
Reposted by Greg Medlock
Excited to share this collaborative study with @ritatamayo.bsky.social showing that E. faecalis influences C. diff morphology through the phase variable CmrRST system! This work was co-led by the amazing team of @ashleyweiss.bsky.social and Jilarie Santos-Santiago!
Enterococcus faecalis modulates phase variation in Clostridioides difficile https://www.biorxiv.org/content/10.1101/2025.07.24.666506v1
July 26, 2025 at 3:08 AM
Reposted by Greg Medlock
Enterococcus faecalis modulates phase variation in Clostridioides difficile https://www.biorxiv.org/content/10.1101/2025.07.24.666506v1
July 25, 2025 at 4:18 AM